When symptoms do occur, they may include: Pelvic pain or a dull ache in the lower abdomen Bloating or abdominal swelling Pain during intercourse Changes in menstrual patterns Difficulty emptying the bladder completely Complications are uncommon but can include cyst rupture (causing sudden, sharp pain), ovarian torsion (twisting of the ovary, which is a surgical emergency), or, rarely, malignant transformation
Common questions about retatrutide, answered objectively No
Men with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not use GLP-1 medications
Patients sometimes describe feeling eager to reach a target level quickly, particularly if they have researched the topic extensively and feel confident about the process
Adipose tissue biology research has particularly benefited from the availability of research-grade retatrutide, as the simultaneous GLP-1R and GCGR activation enables researchers to study distinct pathways of adipocyte lipolysis regulation that were previously difficult to separate experimentally
10.1038/s41569-023-00849-3 53
